Results 21 to 30 of about 2,722 (180)

Endpoints and outcomes for localized scleroderma/morphea: a scoping literature review [PDF]

Pediatric Rheumatology Online Journal
Background Current treatment for localized scleroderma (LS) has been shown to halt disease activity, but little is still known about patient experiences with these treatments, nor is there consensus about optimal measurement strategies for future ...
Alexy Hernandez, Leslie Zapata Leiva, Maria Mutka, Kathryn S. Torok, Leila Ledbetter, Christina K. Zigler   +5 more
doaj   +2 more sources

Durometry as an outcome measure in juvenile localized scleroderma. [PDF]

Br J Dermatol, 2016
Poff S, Li SC, Kelsey CE, Foeldvari I, Torok KS.   +4 more
europepmc   +4 more sources

Juvenile eosinophilic fasciitis: a single center case series [PDF]

Pediatric Rheumatology Online Journal
Background Eosinophilic fasciitis (EF) is a rare disease characterized by skin induration and musculoskeletal abnormalities. Diagnostic criteria for EF are based on adult populations.
Leigh A. Stubbs, Oluwaseun Ogunbona, Emily Beil, Vibha Szafron, Adekunle Adesina, Sara Anvari, Jamie Lai, Andrea Ramirez, Matthew G. Ditzler, Marietta DeGuzman   +9 more
doaj   +2 more sources

Reliability of using an ultrasound scoring measure for juvenile localized scleroderma (jLS) [PDF]

Pediatric Rheumatology Online Journal, 2012
Li Suzanne C, Liebling Melissa S, Dempsey-Robertson Molly, Doria Andrea S, Edgerton Stephanie, Hamer Carsten, Jarrin Jose, Kornyat Tanicka, Malone Michael, Mohanta Arun, Opitz Sven, Ramji Faridali, Zhang Shuzhen, Wittkowski Knut   +13 more
doaj   +2 more sources

Developing juvenile localized scleroderma (jLS) consensus treatment regimens for comparative effectiveness studies [PDF]

Pediatric Rheumatology Online Journal, 2012
Li Suzanne C, Fuhlbrigge Robert C, Dedeoglu Fatma, Ferguson Polly J, Higgins Gloria C, Hong Sandy D, Jacobe Heidi, Lasky Andrew, Laxer Ronald M, Morris Mimi C, Pope Elena, Rabinovich C, Torok Kathryn S   +12 more
doaj   +2 more sources

Neurological and psychological aspects of scleroderma of the face and neck in children

Лечащий Врач, 2021
In the structure of morbidity, among rheumatic diseases in children, juvenile scleroderma takes the third place in frequency after juvenile idiopathic arthritis and systemic lupus erythematosus.
M. S. Pavlova, L. G. Khachatryan, M. K. Osminina, N. A. Geppe, N. S. Podchernyaeva, V. M. Trepilets, M. D. Bogdanova, E. V. Kasanave, E. N. Tjurina, M. D. Velikoretskaya   +9 more
doaj   +1 more source

Localized scleroderma in children

Przegląd Dermatologiczny, 2020
Localized scleroderma is an autoimmune disease affecting the dermis and underlying tissues (subcutaneous tissue, fascia, muscles, bones). The disease mainly occurs in women aged 20–50 years; however, children aged 7–10 years represent about 15% of all ...
Katarzyna A. Wolska-Gawron, Dorota Krasowska   +1 more
doaj   +1 more source

Juvenile Localized Scleroderma from the Perspective of Pediatric Rheumatologist. Aspects of Diagnostics

Вопросы современной педиатрии, 2020
The localized scleroderma (morphea) is the clinical option of the juvenile scleroderma, the third in prevalence rheumatic condition in pediatrics. The article summarizes all the data on the classification, diagnostics, and differential diagnosis of ...
Rinat K. Raupov, Artur I. Imelbaev, Mikhail M. Kostik   +2 more
doaj   +1 more source

Efficacy and safety of methotrexate treatment of juvenile localized scleroderma [PDF]

Pediatric Rheumatology Online Journal, 2008
Osminina MK, Geppe NA, Tougarinova GV, Rabieva GM, Kostina YO   +4 more
doaj   +2 more sources

Peripheral blood cytokine and chemokine profiles in juvenile localized scleroderma: T-helper cell-associated cytokine profiles. [PDF]

Semin Arthritis Rheum, 2015
Torok KS, Kurzinski K, Kelsey C, Yabes J, Magee K, Vallejo AN, Medsger T, Feghali-Bostwick CA.   +7 more
europepmc   +2 more sources